GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $99,274,000 | +2963.1% | 457,697 | +1633.2% | 0.49% | +1646.4% |
| Q2 2020 | $3,241,000 | +7.4% | 26,407 | -23.4% | 0.03% | -22.2% |
| Q1 2020 | $3,018,000 | +573.7% | 34,468 | +703.6% | 0.04% | +1100.0% |
| Q4 2019 | $448,000 | -94.6% | 4,289 | -94.1% | 0.00% | -94.7% |
| Q3 2019 | $8,321,000 | +91.7% | 72,340 | +189.4% | 0.06% | +103.6% |
| Q2 2019 | $4,341,000 | -79.6% | 25,000 | -80.2% | 0.03% | -80.3% |
| Q1 2019 | $21,314,000 | +406.4% | 126,439 | +192.6% | 0.14% | +373.3% |
| Q4 2018 | $4,209,000 | -23.0% | 43,215 | -10.9% | 0.03% | +30.4% |
| Q1 2018 | $5,464,000 | -40.5% | 48,500 | -46.4% | 0.02% | -36.1% |
| Q3 2017 | $9,182,000 | +1280.8% | 90,474 | +1545.0% | 0.04% | +1100.0% |
| Q1 2017 | $665,000 | -67.1% | 5,500 | -78.0% | 0.00% | -81.2% |
| Q3 2014 | $2,021,000 | – | 25,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 450,000 | $55,224,000 | 4.41% |
| Parkman Healthcare Partners LLC | 119,778 | $14,699,000 | 4.14% |
| Sio Capital Management, LLC | 94,984 | $11,656,000 | 3.40% |
| Tamarack Advisers, LP | 90,000 | $11,045,000 | 3.08% |
| Copernicus Capital Management, LLC | 22,000 | $2,700,000 | 2.96% |
| Integral Health Asset Management, LLC | 75,000 | $9,204,000 | 2.76% |
| ETF MANAGERS GROUP, LLC | 480,145 | $58,923,000 | 2.09% |
| AdvisorShares Investments LLC | 29,758 | $3,652,000 | 1.55% |
| Redwood Investments, LLC | 130,444 | $16,008,000 | 1.42% |
| CLOUGH CAPITAL PARTNERS L P | 100,746 | $12,364,000 | 1.21% |